Vision 2035: Difference between revisions
Initial source-linked scientific wiki setup |
Add complete multilingual reference and language navigation |
||
| Line 1: | Line 1: | ||
<div class="wiki-language-nav" style="padding:0.75em; border:1px solid #b5c8cd; border-radius:0.5em; margin-bottom:1em;">[[Vision 2035|English]] · [[Vision 2035/uk|Українська]] · [[Vision 2035/es|Español]] · [[Vision 2035/fr|Français]] · [[Vision 2035/de|Deutsch]] · [[Vision 2035/pt|Português]]</div> | |||
= Vision 2035 = | = Vision 2035 = | ||
'''Vision 2035''' is a developing research and conceptual project. The publisher lists ''Vision 2035 – Medico-Pharmaceutical Law for Human Security'' as published on '''6 March 2026''', DOI [https://doi.org/10.53933/b91avw28 10.53933/b91avw28]. | '''Vision 2035''' is a developing research and conceptual project. The publisher lists ''Vision 2035 – Medico-Pharmaceutical Law for Human Security'' as published on '''6 March 2026''', DOI [https://doi.org/10.53933/b91avw28 10.53933/b91avw28]. | ||
Latest revision as of 00:52, 12 November 2026
Vision 2035
Vision 2035 is a developing research and conceptual project. The publisher lists Vision 2035 – Medico-Pharmaceutical Law for Human Security as published on 6 March 2026, DOI 10.53933/b91avw28.
The 2026 volume proposes integrated governance for health care, medicines, clinical data and related technologies. Its stated concerns include patient rights, safety, accountability and access. These are proposed frameworks and objectives, not a report that implementation outcomes have already been achieved.
The publisher credits Valentyn Shapovalov, Viktoriia Shapovalova, Valerii Shapovalov, Oleksandr Veits, Andrii Diachenko and Alina Osyntseva for this volume.
Revision 2027
The later working revision develops the broader All-Being Security scope and concepts including Recipra. A working draft and a published edition are not interchangeable. Version-specific claims and contributor roles should identify the relevant document and date.
See History and research foundations for the earlier scholarly lineage and People and attribution for attribution boundaries.